We are live on
!
Find out more
FAM
Fred Alger Management Portfolio holdings
AUM
$22.8B
1-Year Est. Return
64.63%
This Fund
S&P 500
This Quarter
Est. Return
+5.88%
1 Year Est. Return
+64.63%
3 Year Est. Return
+243.99%
5 Year Est. Return
+318.3%
10 Year Est. Return
+1,899.64%
AUM
$21.5B
AUM Growth
-$647M
(-2.9%)
Cap. Flow
-$1.48B
Cap. Flow
% of AUM
-6.88%
Top 10 Holdings %
Top 10 Hldgs %
38.78%
Holding
614
New
58
Increased
200
Reduced
215
Closed
65
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$164M |
| 2 |
Salesforce
CRM
|
+$163M |
| 3 |
SBA Communications
SBAC
|
+$130M |
| 4 |
Boeing
BA
|
+$128M |
| 5 |
RHT
Red Hat Inc
RHT
|
+$120M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$496M |
| 2 |
Apple
AAPL
|
+$260M |
| 3 |
Amazon
AMZN
|
+$179M |
| 4 |
Microchip Technology
MCHP
|
+$130M |
| 5 |
Crown Castle
CCI
|
+$129M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.61% |
| 2 | Consumer Discretionary | 16.32% |
| 3 | Healthcare | 15.75% |
| 4 | Communication Services | 12.15% |
| 5 | Financials | 11.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
401
Peapack-Gladstone Financial
PGC
$846M
| $142K | ﹤0.01% |
4,252
| – | – |
|
|
XENT
402
DELISTED
Intersect ENT, Inc
XENT
| $118K | ﹤0.01% |
+3,000
| New | +$110K |
|
403
CytomX Therapeutics
CTMX
$701M
| $114K | ﹤0.01% |
+4,000
| New | +$114K |
|
|
CBIO
404
Crescent Biopharma
CBIO
$608M
| $114K | ﹤0.01% |
70
+50
| +250% | +$104K |
|
405
Estee Lauder
EL
$30.7B
| $109K | ﹤0.01% |
729
-150
| -17% | -$20.8K |
|
406
Nektar Therapeutics
NKTR
$2.39B
| $106K | ﹤0.01% |
+67
| New | +$86.3K |
|
407
Tandem Diabetes Care
TNDM
$1.22B
| $99K | ﹤0.01% |
+20,000
| New | +$64.5K |
|
|
CALA
408
DELISTED
Calithera Biosciences, Inc
CALA
| $88K | ﹤0.01% |
700
+200
| +40% | +$31.2K |
|
|
DERM
409
DELISTED
Dermira, Inc.
DERM
| $88K | ﹤0.01% |
+11,000
| New | +$239K |
|
410
eBay
EBAY
$52.1B
| $84K | ﹤0.01% |
2,090
-276
| -12% | -$11.4K |
|
411
ASML
ASML
$608B
| $83K | ﹤0.01% |
420
-8,285
| -95% | -$1.63M |
|
412
VF Corp
VFC
$7.16B
| $78K | ﹤0.01% |
1,124
+740
| +193% | +$53.5K |
|
413
Verisk Analytics
VRSK
$27.8B
| $78K | ﹤0.01% |
749
| – | – |
|
414
Arista Networks
ANET
$214B
| $77K | ﹤0.01% |
4,816
+688
| +17% | +$11.6K |
|
|
RARX
415
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
| $74K | ﹤0.01% |
14,000
-3,000
| -18% | -$21.4K |
|
416
TransUnion
TRU
$16.1B
| $73K | ﹤0.01% |
1,289
+576
| +81% | +$33.2K |
|
417
Marriott International
MAR
$101B
| $72K | ﹤0.01% |
527
+428
| +432% | +$60K |
|
418
L3Harris
LHX
$56.9B
| $71K | ﹤0.01% |
439
+262
| +148% | +$40K |
|
419
IDEX
IEX
$16.6B
| $69K | ﹤0.01% |
482
+291
| +152% | +$40.6K |
|
420
SEI Investments
SEIC
$12.4B
| $69K | ﹤0.01% |
919
+547
| +147% | +$40.7K |
|
421
Target
TGT
$65.5B
| $69K | ﹤0.01% |
1,001
+132
| +15% | +$9.61K |
|
|
MRNS
422
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $69K | ﹤0.01% |
+4,500
| New | +$107K |
|
423
Amphenol
APH
$177B
| $68K | ﹤0.01% |
3,144
-44
| -1% | -$991 |
|
|
AKAO
424
DELISTED
Achaogen Inc
AKAO
| $65K | ﹤0.01% |
+5,000
| New | +$56.7K |
|
|
ESRX
425
DELISTED
Express Scripts Holding Company
ESRX
| $60K | ﹤0.01% |
868
| – | – |
|
Similar funds
CAM
BA
AM
SAM
CHP
Fred Alger Management's Q1 2018 Portfolio in Review
As of Q1 2018, Fred Alger Management held 614 positions worth $21.5B, down 2.9% from $22.2B the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Fred Alger Management withdrew a net $1.48B in Q1 2018, closing 65 positions and reducing 215 holdings. Its most notable exit was Broadcom, an estimated $496M position sold in full.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Fred Alger Management opened a new position in Zayo Group Holdings, Inc. worth $33.9M.
- Fred Alger Management's largest Q1 2018 buy was Zayo Group Holdings, Inc.: 991,263 shares worth $33.9M.
- Fred Alger Management added most to Microsoft in Q1 2018, an estimated $164M increase.
- Fred Alger Management's biggest Q1 2018 reduction was Apple, cutting an estimated $260M.
- Fred Alger Management fully exited Broadcom in Q1 2018, selling an estimated $496M.
- Fred Alger Management's ten largest holdings make up 39% of its $21.5B portfolio in Q1 2018.
- Fred Alger Management opened 58 new positions and closed 65 in Q1 2018.
- Fred Alger Management's portfolio value fell 2.9% quarter-over-quarter to $21.5B.
Based on Fred Alger Management's 13F filing for Q1 2018, filed 10 May 2018.